Magnafloxacin

Magnafloxacin Uses, Dosage, Side Effects, Food Interaction and all others data.

A broad-spectrum 6-fluoronaphthyridinone antibacterial agent (fluoroquinolones) structurally related to nalidixic acid.

Magnafloxacin is a quinolone/fluoroquinolone antibiotic. Magnafloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Magnafloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. Magnafloxacin may be active against pathogens resistant to drugs that act by different mechanisms.

Trade Name Magnafloxacin
Availability Discontinued
Generic Enoxacin
Enoxacin Other Names Enoxacin, Enoxacina, Énoxacine, Enoxacino, Enoxacinum
Related Drugs amoxicillin, doxycycline, ciprofloxacin, cephalexin, metronidazole, azithromycin, ceftriaxone, levofloxacin, Augmentin, amoxicillin / clavulanate
Type
Formula C15H17FN4O3
Weight Average: 320.3189
Monoisotopic: 320.128468635
Protein binding

Enoxacin is approximately 40% bound to plasma proteins in healthy subjects and is approximately 14% bound to plasma proteins in patients with impaired renal function.

Groups Approved, Investigational
Therapeutic Class
Manufacturer
Available Country Egypt
Last Updated: September 19, 2023 at 7:00 am
Magnafloxacin
Magnafloxacin

Uses

For the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae, (2) uncomplicated urinary tract infections (cystitis) due to Escherichia coli, Staphylococcus epidermidis, or Staphylococcus saprophyticus, and (3) complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, or Enterobacter cloacae.

How Magnafloxacin works

Magnafloxacin exerts its bactericidal action via the inhibition of the essential bacterial enzyme DNA gyrase (DNA Topoisomerase II).

Magnafloxacin multivitamins interaction

[Moderate] ADJUST DOSING INTERVAL: Oral preparations that contain magnesium, aluminum, or calcium may significantly decrease the gastrointestinal absorption of quinolone antibiotics.

Absorption may also be reduced by sucralfate, which contains aluminum, as well as other polyvalent cations such as iron and zinc.

The mechanism is chelation of quinolones by polyvalent cations, forming a complex that is poorly absorbed from the gastrointestinal tract.

The bioavailability of ciprofloxacin has been reported to decrease by as much as 90% when administered with antacids containing aluminum or magnesium hydroxide.

When coadministration cannot be avoided, quinolone antibiotics should be dosed either 2 to 4 hours before or 4 to 6 hours after polyvalent cation-containing products to minimize the potential for interaction.

When coadministered with Suprep Bowel Prep (magnesium

Please consult individual product labeling for specific recommendations.

Elimination Route

Rapidly absorbed following oral administration, with an absolute oral bioavailability of approximately 90%.

Half Life

Plasma half-life is 3 to 6 hours.

Innovators Monograph

You find simplified version here Magnafloxacin

*** Taking medicines without doctor's advice can cause long-term problems.
Share